Early methyl donor deficiency may induce persistent brain defects by reducing Stat3 signaling targeted by miR-124.
The methyl donors folate (vitamin B9) and vitamin B12 are centrepieces of the one-carbon metabolism that has a key role in transmethylation reactions, and thus in epigenetic and epigenomic regulations. Low dietary intakes of folate and vitamin B12 are frequent, especially in pregnant women and in the elderly, and deficiency constitutes a risk factor for various diseases, including neurological and developmental disorders. In this respect, both vitamins are essential for normal brain development, and have a role in neuroplasticity and in the maintenance of neuronal integrity. The consequences of a methyl donor deficiency (MDD) were studied both in vivo in rats exposed in utero, and in vitro in hippocampal progenitors (H19-7 cell line). Deficiency was associated with growth retardation at embryonic day 20 (E20) and postnatally with long-term brain defects in selective areas. mRNA and protein levels of the transcription factor Stat3 were found to be decreased in the brains of deprived fetuses and in differentiating progenitors (62 and 48% for total Stat3 protein, respectively), along with a strong reduction in its phosphorylation at both Tyr⁷⁰⁵ and Ser⁷²⁷ residues. Vitamin shortage also affected upstream kinases of Stat3 signaling pathway (phospho-Erk1/2, phospho-Src, phospho-JNK, and phospho-p38) as well as downstream target gene products (Bcl-2 and Bcl-xL), thus promoting apoptosis. Conversely, the expression of the Stat3 regulator miR-124 was upregulated in deficiency conditions (≥65%), and its silencing by using siRNA partly restored Stat3 signaling in hippocampal neurons by increasing specifically the phosphorylation of Erk1/2 and Src kinases. Furthermore, miR-124 siRNA improved the phenotype of deprived cells, with enhanced neurite outgrowth. Taken together, our data suggest that downregulation of Stat3 signaling by miR-124 would be a key factor in the deleterious effects of MDD on brain development.
Faculté de Médecine, Inserm U954, Vandoeuvre-lès-Nancy, France.
R
R
Kerek
A
A
Geoffroy
A
A
Bison
N
N
Martin
N
N
Akchiche
G
G
Pourié
D
D
Helle
J-L
JL
Guéant
C
C
Bossenmeyer-Pourié
J-L
JL
Daval
D000818:Animals; D001921:Brain / Q000196:embryology / Q000378:metabolism; D001927:Brain Diseases / Q000378:metabolism*; D002460:Cell Line; D047109:Fetal Development / Q000235:genetics; D005492:Folic Acid / Q000378:metabolism; D006624:Hippocampus / Q000166:cytology / Q000378:metabolism; D035683:MicroRNAs / Q000378:metabolism / Q000502:physiology*; D010766:Phosphorylation; D051381:Rats; D050796:STAT3 Transcription Factor / Q000378:metabolism / Q000502:physiology*; D015398:Signal Transduction; D014806:Vitamin B 12 Deficiency
C548144:MIRN124 microRNA, rat; D035683:MicroRNAs; D050796:STAT3 Transcription Factor; C494088:Stat3 protein, rat; D005492:Folic Acid